The mystery of ibogaine: can an African psychedelic cure addiction?

Copyright Omni Publications International Ltd. 1993 Omni July, 1993 SECTION: Vol. 15 ; No. 9 ; Pg. 14; ISSN: 0149-8711 LENGTH: 757 words HEADLINE: The mystery of ibogaine: can an African psychedelic cure addiction? BYLINE: Nadis, Steve BODY: Wild claims have been made about ibogaine, an hallucinogenic substance derived from …

Continue reading

Hallucinogen Being Studied As Treatment For Addiction

Copyright 1992 Globe Newspaper Company The Boston Globe November 9, 1992, Monday, City Edition SECTION: SCIENCE & TECHNOLOGY; Pg. 29 LENGTH: 1371 words HEADLINE: HALLUCINOGEN BEING STUDIED AS TREATMENT FOR ADDICTION; PHARMACOLOGY BYLINE: By Dolores Kong, Globe Staff BODY: In the urgent search for new treatments for cocaine and heroin …

Continue reading

Ibogaine and the FDA

NCTR 2002-2003 Research Plans – Neurotoxicology Title: Effects of Ibogaine on Neurotransmitter Systems, Generation of Free Radicals and Nitric Oxide Synthase Activity: Correlation with Neurohistological Evaluations in Mouse and Rat Brain Determine the effects of ibogaine on dopamine, serotonin and their metabolite concentrations in different regions of mouse and rat …

Continue reading

Ibogaine Patents @ the USPO

Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to …

Continue reading

Ibogaine Abstracts on PubMed

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC …

Continue reading

2007: 2nd National Conference on Methamphetamine

2nd National Conference on Methamphetamine The Harm Reduction Project Ibogaine Panel Saturday, February 3rd, 2007 Hilton Salt Lake City Center 255 South West Temple, Salt Lake City, Utah, United States 84101 Tel: +1-801-328-2000 Fax: +1-801-238-4888 Presenters / Participants Dana Beal, Cures Not Wars Patrick K. Kroupa, MindVox Howard Lotsof, Dora …

Continue reading

Addicted to Addiction

University of Miami’s Deborah Mash believes ibogaine could be the wonder drug to end all drugs. And she’s ready to risk everything to prove it. By Paula Park (Originally published in Miami New Times — 09.11.1997) Deborah Mash and her three colleagues from the University of Miami strolled into the …

Continue reading

An Array of New Drugs…

An Array of New Drugs Show Promise in Fighting Addiction by: Gautam Naik The Wall Street Journal — (July 15, 2002) Could people be inoculated against drug addictions the way they can against some infectious diseases? It may be possible. Despite disappointing past efforts to treat addictions with medicine, recent …

Continue reading